In January, Marina Litvin, MD, an Associate Professor of Medicine at WashU Medicine’s Division of Endocrinology, Metabolism and Lipid Research, published an editorial titled “Metabolic Syndrome in the Post-ETI Era” in the Journal of Cystic Fibrosis. Cystic fibrosis (CF) is an autosomal recessive disease caused by defective cystic fibrosis transmembrane regulator channels which leads to […]
Litvin details current and emerging therapies in cystic fibrosis
